PremiumCompany AnnouncementsAstraZeneca Targets Pediatric Asthma Gains With New Glycopyrronium Trial16h agoAZN
PremiumCompany AnnouncementsAstraZeneca Advances Off‑the‑Shelf CAR‑T Program in Tough‑to‑Treat Multiple Myeloma16h agoAZN
PremiumCompany AnnouncementsAstraZeneca’s CREW Study: Real-World Tezspire Data That Could Shape Respiratory Revenues16h agoAZN